These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20087690)

  • 21. Science and norms in policies for sustainable development: assessing and managing risks of chemical substances and genetically modified organisms in the European Union.
    Karlsson M
    Regul Toxicol Pharmacol; 2006 Feb; 44(1):49-56. PubMed ID: 16213076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The meaningless pseudo-category of "GMOs": The trouble with the "new techniques" for genetically modifying crops demonstrates the illogical process-based definition of GMOs in EU regulation.
    Tagliabue G
    EMBO Rep; 2016 Jan; 17(1):10-3. PubMed ID: 26559524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Are current EU policies on GMOs justified?
    Christiansen AT; Andersen MM; Kappel K
    Transgenic Res; 2019 Apr; 28(2):267-286. PubMed ID: 30838488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GM crops-lessons from medicine.
    Hunter J; Duff G
    Science; 2016 Sep; 353(6305):1187. PubMed ID: 27634500
    [No Abstract]   [Full Text] [Related]  

  • 25. EU biotech crop regulations and environmental risk: a case of the emperor's new clothes?
    Morris SH
    Trends Biotechnol; 2007 Jan; 25(1):2-6. PubMed ID: 17113665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Options to Reform the European Union Legislation on GMOs: Post-authorization and Beyond.
    Eriksson D; Custers R; Edvardsson Björnberg K; Hansson SO; Purnhagen K; Qaim M; Romeis J; Schiemann J; Schleissing S; Tosun J; Visser RGF
    Trends Biotechnol; 2020 May; 38(5):465-467. PubMed ID: 32302577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Putting problem formulation at the forefront of GMO risk analysis.
    Tepfer M; Racovita M; Craig W
    GM Crops Food; 2013; 4(1):10-5. PubMed ID: 23160540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The structuring of GMO release and evaluation in EU law.
    von Kries C; Winter G
    Biotechnol J; 2012 Apr; 7(4):569-81. PubMed ID: 22121045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetically modified organisms: do the benefits outweigh the risks?
    Hug K
    Medicina (Kaunas); 2008; 44(2):87-99. PubMed ID: 18344661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The current state of GMO governance: are we ready for GM animals?
    Vàzquez-Salat N; Salter B; Smets G; Houdebine LM
    Biotechnol Adv; 2012; 30(6):1336-43. PubMed ID: 22361646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of existing environmental networks for the post-market monitoring of GM crop cultivation in the EU.
    Smets G; Alcalde E; Andres D; Carron D; Delzenne P; Heise A; Legris G; Martinez Parrilla M; Verhaert J; Wandelt C; Ilegems M; Rüdelsheim P
    Environ Sci Process Impacts; 2014 Jul; 16(7):1754-63. PubMed ID: 24836113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of GMOs in China.
    Liu Y
    J Int Bioethique; 2008 Dec; 19(4):139-58, 167. PubMed ID: 19492727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The release of genetically modified crops into the environment. Part I. Overview of current status and regulations.
    Nap JP; Metz PL; Escaler M; Conner AJ
    Plant J; 2003 Jan; 33(1):1-18. PubMed ID: 12943538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case studies on genetically modified organisms (GMOs): Potential risk scenarios and associated health indicators.
    de Santis B; Stockhofe N; Wal JM; Weesendorp E; Lallès JP; van Dijk J; Kok E; De Giacomo M; Einspanier R; Onori R; Brera C; Bikker P; van der Meulen J; Kleter G
    Food Chem Toxicol; 2018 Jul; 117():36-65. PubMed ID: 28859885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biosafety management and commercial use of genetically modified crops in China.
    Li Y; Peng Y; Hallerman EM; Wu K
    Plant Cell Rep; 2014 Apr; 33(4):565-73. PubMed ID: 24493253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biosafety of bee pollinators in genetically modified agro-ecosystems: Current approach and further development in the EU.
    Arpaia S; Smagghe G; Sweet JB
    Pest Manag Sci; 2021 Jun; 77(6):2659-2666. PubMed ID: 33470515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clarifying the regulation of genome editing in Australia: situation for genetically modified organisms.
    Thygesen P
    Transgenic Res; 2019 Aug; 28(Suppl 2):151-159. PubMed ID: 31321698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toward a workable biosafety system for regulating genetically modified organisms in Ethiopia: balancing conservation and competitiveness.
    Abraham A
    GM Crops Food; 2013; 4(1):28-35. PubMed ID: 23580251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Genetically Modified Organism Medicinal Framework in Europe, United States, and Japan: Underlying Scientific Principles and Considerations Toward the Development of Gene Therapy and Genetically Modified Cell-Based Products.
    Bachtarzi H; Farries T
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):114-128. PubMed ID: 31111736
    [No Abstract]   [Full Text] [Related]  

  • 40. Points to consider in seeking biosafety approval for research, testing, and environmental release of experimental genetically modified biocontrol products during research and development.
    Tonui WK; Ahuja V; Beech CJ; Connolly JB; Dass B; Glandorf DCM; James S; Muchiri JN; Mugoya CF; Okoree EA; Quemada H; Romeis J
    Transgenic Res; 2022 Dec; 31(6):607-623. PubMed ID: 36194213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.